We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PUT
Citigroup
C
$223B
| $4.87M | 0.13% |
94,000
-195,700
| -68% | -$10.4M |
|
127
iShares MSCI Mexico ETF
EWW
$1.91B
| $4.84M | 0.13% |
97,132
+43,625
| +82% | +$2.33M |
|
128
Global Payments
GPN
$23B
| $4.82M | 0.13% |
74,777
+31,779
| +74% | +$2.14M |
|
129
Gilead Sciences
GILD
$162B
| $4.78M | 0.13% |
47,277
-173,721
| -79% | -$18.1M |
|
130
CALL
Cigna
CI
$77B
| $4.7M | 0.12% |
32,100
+100
| +0.3% | +$13.7K |
|
131
Phillips 66
PSX
$83.3B
| $4.7M | 0.12% |
57,389
-176,916
| -76% | -$15.3M |
|
132
Amgen
AMGN
$203B
| $4.69M | 0.12% |
28,906
+22,973
| +387% | +$3.61M |
|
133
Veeva Systems
VEEV
$31.6B
| $4.64M | 0.12% |
+161,000
| New | +$4.3M |
|
134
CALL
iShares China Large-Cap ETF
FXI
$4.22B
| $4.64M | 0.12% |
+131,500
| New | +$4.94M |
|
|
MZTI
135
The Marzetti Company
MZTI
$2.95B
| $4.64M | 0.12% |
+40,156
| New | +$4.4M |
|
136
CALL
Boeing
BA
$167B
| $4.63M | 0.12% |
32,000
+10,500
| +49% | +$1.51M |
|
|
VWR
137
DELISTED
VWR Corporation
VWR
| $4.63M | 0.12% |
+163,426
| New | +$4.34M |
|
138
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
| $4.56M | 0.12% |
+210,000
| New | +$4.66M |
|
139
CALL
Microsoft
MSFT
$2.89T
| $4.54M | 0.12% |
81,800
+6,000
| +8% | +$316K |
|
|
140
PUT
Microsoft
MSFT
$2.89T
| $4.54M | 0.12% |
81,800
+6,000
| +8% | +$316K |
|
141
HF Sinclair
DINO
$16.4B
| $4.52M | 0.12% |
113,348
+93,577
| +473% | +$4.43M |
|
|
142
Regeneron Pharmaceuticals
REGN
$69.9B
| $4.49M | 0.12% |
8,277
-85,285
| -91% | -$46.2M |
|
143
National Fuel Gas
NFG
$7.67B
| $4.49M | 0.12% |
105,049
+87,336
| +493% | +$4.15M |
|
144
Canadian Pacific Kansas City
CP
$81.1B
| $4.46M | 0.12% |
174,650
+145,965
| +509% | +$4.1M |
|
145
NOV
NOV
$7.35B
| $4.43M | 0.12% |
+132,204
| New | +$4.91M |
|
|
TFCFA
146
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $4.43M | 0.12% |
162,988
+145,847
| +851% | +$4.23M |
|
147
Fulton Financial
FULT
$4.67B
| $4.38M | 0.12% |
336,895
+297,600
| +757% | +$3.99M |
|
|
HES
148
DELISTED
Hess
HES
| $4.36M | 0.12% |
89,957
+51,906
| +136% | +$2.95M |
|
149
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.8B
| $4.34M | 0.11% |
36,000
+24,000
| +200% | +$2.92M |
|
150
Travel + Leisure Co
TNL
$4.68B
| $4.29M | 0.11% |
130,809
+94,738
| +263% | +$3.27M |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
BWP
MC
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.